Our objective was to analyze the ATRX and ZNRF3 protein expression in an ACC cohort; we chose the immunohistochemistry technique because of its availability and ease of use, aiming to bring pan-genomic studies closer to the clinical practice. The gene discussed is ATRX; the disease is adrenal cortex carcinoma.